ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Engineered bacteria detect gut inflammation in mice

Bacteria maintain ability to respond to inflammation product for more than one thousand cell divisions

by Celia Henry Arnaud
June 5, 2017 | APPEARED IN VOLUME 95, ISSUE 23

A new strain of engineered bacteria can detect inflammation in the colon of mice even after more than 1,000 bacterial divisions, researchers report (Nat. Biotechnol. 2017, DOI: 10.1038/nbt.3879). Such a microbe could help doctors diagnose and monitor diseases such as inflammatory bowel disease.

Pamela A. Silver and coworkers at Harvard University engineered nonpathogenic Escherichia coli to detect and respond to tetrathionate, a transient product of a reactive oxygen species released by intestinal cells during inflammation.

The researchers inserted two genetic circuits into the bacterial genome. The first circuit produces the transcriptional factor Cro in response to tetrathionate, and Cro triggers a second “memory” circuit to produce the protein β-galactosidase. Even when tetrathionate is no longer around, the bacteria “remember” the exposure and continue to produce both proteins. The researchers monitored inflammation in mice treated with the microbes by measuring β-galactosidase in the animals’ feces.

The bacteria produced β-galactosidase in mice with intestinal infections and those genetically engineered to have high levels of inflammation. The researchers were even able to detect signs of inflammation in mice that had no visible signs of it, which suggests that the bacteria can detect low-level, subclinical inflammation.

Because the bacteria didn’t acquire mutations that shut down the engineered circuits, they could maintain their responsiveness to tetrathionate for at least six months, which equals approximately 1,600 generations of engineered bacteria.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment